1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Data
2.2. Assumptions
3. EXECUTIVE SUMMARY
3.1. Research Highlights
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter’s Five Force Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
5. NORTH AMERICA DRUG DELIVERY MARKET BY TYPE
5.1. Introduction
5.2. Inhalation Drug Delivery
5.3. Injectable Drug Delivery
5.4. Nasal Drug Delivery
5.5. Oral Drug Delivery
5.6. Transdermal Drug Delivery
6. NORTH AMERICA DRUG DELIVERY MARKET BY APPLICATION
6.1. Introduction
6.2. Disease Treatment
6.3. Research/ Academic Purpose
7. NORTH AMERICA DRUG DELIVERY MARKET BY COUNTRY
7.1. Introduction
7.2. United States
7.3. Canada
7.4. Mexico
8. COMPETITIVE ENVIRONMENT AND ANALYSIS
8.1. Major Players and Strategy Analysis
8.2. Market Share Analysis
8.3. Mergers, Acquisitions, Agreements, and Collaborations
9. COMPANY PROFILES
9.1. AstraZeneca PLC
9.2. West Pharmaceutical Services, Inc.
9.3. Becton, Dickinson, and Company
9.4. Medtronic PLC
9.5. Boston Scientific Corporation
9.6. Cipla, Inc.
9.7. 3M Company
9.8. Stevanato Group (Stevanato Holding S.R.L.)
9.9. Gerresheimer AG